Rainier Therapeutics (Vofatamab) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Rainier Therapeutics (Vofatamab) General Information

Description

A cold antibody drug.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • San Leandro, CA
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • San Leandro, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rainier Therapeutics (Vofatamab) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rainier Therapeutics (Vofatamab)‘s full profile, request access.

Request a free trial

Rainier Therapeutics (Vofatamab) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Rainier Therapeutics (Vofatamab)‘s full profile, request access.

Request a free trial

Rainier Therapeutics (Vofatamab) FAQs

  • Where is Rainier Therapeutics (Vofatamab) headquartered?

    Rainier Therapeutics (Vofatamab) is headquartered in San Leandro, CA.

  • What industry is Rainier Therapeutics (Vofatamab) in?

    Rainier Therapeutics (Vofatamab)’s primary industry is Buildings and Property.

  • Is Rainier Therapeutics (Vofatamab) a private or public company?

    Rainier Therapeutics (Vofatamab) is a Private company.

  • What is Rainier Therapeutics (Vofatamab)’s current revenue?

    The current revenue for Rainier Therapeutics (Vofatamab) is .

  • Who are Rainier Therapeutics (Vofatamab)’s investors?

    Rainier Therapeutics has invested in Rainier Therapeutics (Vofatamab).

  • When was Rainier Therapeutics (Vofatamab) acquired?

    Rainier Therapeutics (Vofatamab) was acquired on 01-Sep-2022.

  • Who acquired Rainier Therapeutics (Vofatamab)?

    Rainier Therapeutics (Vofatamab) was acquired by Fusion Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process